NCT05733312View on ClinicalTrials.gov

Extracellular Impact of Ultrasound-induced Blood-brain Barrier Disruption

NARecruitingINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

January 24, 2024

Primary Completion Date

January 15, 2027

Study Completion Date

January 15, 2027

Conditions
Brain Tumor
Interventions
DEVICE

InSightec's ExAblate Neuro Model 4000 Type 2.0 (220 KHz) system

Focused ultrasound which targets energy to a specific area in the brain based on imaging and disrupts the blood brain barrier which keeps certain drugs and other molecules out of the brain.

Trial Locations (1)

55905

RECRUITING

Mayo Clinic Minnesota, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT05733312 - Extracellular Impact of Ultrasound-induced Blood-brain Barrier Disruption | Biotech Hunter | Biotech Hunter